INDP
INDP
NASDAQ · Biotechnology

Indaptus Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.75
+0.00 (+0.00%)
As of May 16, 2:35 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,229.7% upside
Low Target $30.54
Average Target $40.77
High Target $54.50
Current Price $1.75
Current
$1.75
Target
$40.77
$30.54 $40.77 avg $54.50
Scenario Analysis
Bear Case
$30.54
1,645.1%
Low target
Base Case
$40.77
+2,229.7%
Avg target
Bull Case
$54.50
+3,014.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$19.91
-91.2% from high
52-Week Low
$1.51
+15.9% from low
Target vs 52W High
$40.77
+104.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%